Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging

By Yì-Xiáng J. Wáng, S. Hussain, G. Krestin. European Radiology, 2001

850 citations recorded by the source corpus.

Subfields: Biomaterials, Biomedical Engineering, Radiology, Nuclear Medicine and Imaging

View Paper: https://www.semanticscholar.org/paper/ab113732e500e6eb6aa9a8ed764aa0ddabf12d27

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Biomaterials

1. A. Anselmo
2. S. Mitragotri

In Biomedical Engineering

1. A. Anselmo
2. S. Mitragotri
3. Fabian Kiessling
4. T. Lammers

In Radiology, Nuclear Medicine and Imaging

1. S. Mitragotri

Citations in the corpus

• Magnetic Nanoparticles: Surface Effects and Properties Related to Biomedicine Applications (2013, methodology): “Due to their high T2 relaxivity (relaxation rate per concentration of MNPs) colloidal suspensions of MNP have been considered for use as MRI CA [160–166].”
• Nanoparticles in the clinic (2016, background): “Alongside colloid-based iron-replacement therapies, similar iron-oxide nanoparticles are clinically approved as contrast agents for MRI (Table 1).(45,46) For imaging applications, the innate magnetic responsiveness of iron-oxide nanoparticles is used with MRI to generate contrast for imaging a varie”
• Tuning the Magnetic Properties of Nanoparticles (2013, background): “The past decade has seen numerous studies evaluating the effect of the core as well as the coating on the relaxation of the surrounding protons for their use as MRI contrast agents [120,121].”
• Iron Oxide Nanoparticles: Diagnostic, Therapeutic and Theranostic Applications (2019, background): “[137,138], for angiography as a blood pool agent [139] and for visualizing inflammatory lesions like atherosclerotic plaques [140].”
• THE BIG PICTURE ON SMALL MEDICINE: THE STATE OF NANOMEDICINE PRODUCTS APPROVED FOR USE OR IN CLINICAL TRIALS (2012, neutral): “Five approved applications utilizing iron oxide NPs for in vivo MRI enhancement were identified, with another four under clinical investigation.(79,80) The iron oxide NPs passively collect in different tissues and provide enhanced contrast due to localized magnetic effects.”